AICAR vs MOTS-c — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
AICAR (Acadesine) is a cell-permeable adenosine analog that is phosphorylated intracellularly to ZMP - a structural mimic of AMP that directly activates AMP-activated protein kinase (AMPK). AMPK is the master metabolic switch triggered by exercise, fasting, and caloric restrictio...
Calculate AICAR dose →MOTS-c is a 16-amino acid mitochondrial-derived peptide encoded within mitochondrial DNA, functioning as a mitohormone. It enhances insulin sensitivity, improves exercise capacity, and may extend healthspan. Plasma levels decline with age and metabolic disease. Phase I research s...
Calculate MOTS-c dose →| Parameter | AICAR | MOTS-c |
|---|---|---|
| Category | Mitochondrial & Longevity | Mitochondrial & Longevity |
| Research | Extensively Studied | Extensively Studied |
| Half-Life | ~1–2 hours | 4 hours |
| Typical Dose | 250–500 mg (clinical IV); 50–100 mg (research SC) | 5–15 mg |
| Frequency | Once daily | Daily or 3× per week |
| Route | Subcutaneous / Intravenous | Subcutaneous |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.